Global Amifostine Market Research Report 2011-2023
- HEY2225287
- 88 Pages
- November 2017
- Healthcare
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
The global Amifostine market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
400mg/Dose
500mg/Dose
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Clinigen Group
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 400mg/Dose
1.2.1.2 500mg/Dose
1.2.2 by Application
1.2.2.1 Ovarian Cancer Adjuvant Therapy
1.2.2.2 Head and Neck Cancer Adjuvant Therapy
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 400mg/Dose Market, 2011-2016
4.1.2 500mg/Dose Market, 2011-2016
4.2 Market Forecast
4.2.1 400mg/Dose Market Forecast, 2017-2022
4.2.2 500mg/Dose Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Ovarian Cancer Adjuvant Therapy Market, 2011-2016
5.1.2 Head and Neck Cancer Adjuvant Therapy Market, 2011-2016
5.1.3 Others Market, 2011-2016
5.2 Market Forecast
5.2.1 Ovarian Cancer Adjuvant Therapy Market Forecast, 2017-2022
5.2.2 Head and Neck Cancer Adjuvant Therapy Market Forecast, 2017-2022
5.2.3 Others Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Clinigen Group
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Sun Pharmaceutical
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Taj Pharmaceuticals
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Merro Pharmaceutical
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Luye Pharma
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Mingren Pharma
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion
List Of Tables
Table Product Specifications of Amifostine
Table Products Segment of Amifostine
Table 400mg/Dose Overview
Table 500mg/Dose Overview
Table Global Amifostine Market by Type, 2011-2022 (USD Million)
Table Application Segment of Amifostine
Table Ovarian Cancer Adjuvant Therapy Overview
Table Head and Neck Cancer Adjuvant Therapy Overview
Table Others Overview
Table Global Amifostine Market by Application, 2011-2022 (USD Million)
Table Global Amifostine Market by Region, 2011-2022 (USD Million)
Table Cost of Amifostine
Table Market Dynamics
Table Policy of Amifostine
Table GDP of Major Countries
Table 400mg/Dose CAGR by Revenue and Volume, 2011-2016
Table 500mg/Dose CAGR by Revenue and Volume, 2011-2016
Table 400mg/Dose CAGR by Revenue and Volume, 2012-2022
Table 500mg/Dose CAGR by Revenue and Volume, 2012-2022
Table Ovarian Cancer Adjuvant Therapy CAGR by Revenue and Volume, 2011-2016
Table Head and Neck Cancer Adjuvant Therapy CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016
List Of Figures
Figure Amifostine Picture
Figure Industry Chain Structure of Amifostine
Figure SWOT of Amifostine
Figure 400mg/Dose Market Size and Growth, 2011-2016 (USD Million)
Figure 400mg/Dose Market Size and Growth, 2011-2016 (in Volume)
Figure 500mg/Dose Market Size and Growth, 2011-2016 (USD Million)
Figure 500mg/Dose Market Size and Growth, 2011-2016 (in Volume)
Figure 400mg/Dose Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure 400mg/Dose Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure 500mg/Dose Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure 500mg/Dose Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Ovarian Cancer Adjuvant Therapy Market Size and Growth, 2011-2016 (USD Million)
Figure Ovarian Cancer Adjuvant Therapy Market Size and Growth, 2011-2016 (in Volume)
Figure Head and Neck Cancer Adjuvant Therapy Market Size and Growth, 2011-2016 (USD Million)
Figure Head and Neck Cancer Adjuvant Therapy Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Ovarian Cancer Adjuvant Therapy Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Ovarian Cancer Adjuvant Therapy Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Head and Neck Cancer Adjuvant Therapy Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Head and Neck Cancer Adjuvant Therapy Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Amifostine Market Concentration by Region
Figure Marketing Channels Overview
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
